Gistem Research

Research and development of therapies based on stem cell derivatives

Who are we?

A team of professionals pioneers in the discovery of the therapeutic potential of the hUCESC secretome and exosomes.

Our mission is to bring affordable therapies based on stem cell derivatives and easy access to patients with unmet medical needs. Founded in Gijón in 2016. At GiStem Research, we have successfully met the challenge of producing high-performance secretome and its derivatives in a reproducible and cost-effective manner, positioning ourselves as a unique innovation platform.

This development has opened up the possibility of several potential clinical applications for secretome-based therapies. Our first secretome-based product from hUCESC has generated promising preclinical data in immunoregulation, healing and regeneration, and our first two programs are expected to enter the clinic in 2026 and 2027.

What do we do ?

Gistem Research is a pioneer in the development of innovative therapies for pathologies for which there is no effective treatment.

GiStem’s therapeutic approach is based on stem cell research conducted by its founders in various Spanish institutions.

Why work with us?

Working with GiStem Research, S.L. is a great opportunity for various stakeholders.

Whether you are an investor looking for high-growth biotechnology opportunities, a researcher seeking cutting-edge stem cell technology, or a company interested in collaborative partnerships, GiStem Research offers a unique and promising avenue in the field of regenerative medicine and extracellular vesicle-based therapies.